These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 10997687)
21. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view. Chilelli NC; Burlina S; Lapolla A Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818 [TBL] [Abstract][Full Text] [Related]
22. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Lee TS; Saltsman KA; Ohashi H; King GL Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5141-5. PubMed ID: 2740348 [TBL] [Abstract][Full Text] [Related]
23. Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Ramana KV; Friedrich B; Tammali R; West MB; Bhatnagar A; Srivastava SK Diabetes; 2005 Mar; 54(3):818-29. PubMed ID: 15734861 [TBL] [Abstract][Full Text] [Related]
24. Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes. Madonna R; De Caterina R Vascul Pharmacol; 2011; 54(3-6):68-74. PubMed ID: 21453786 [TBL] [Abstract][Full Text] [Related]
25. Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Ramana KV; Friedrich B; Srivastava S; Bhatnagar A; Srivastava SK Diabetes; 2004 Nov; 53(11):2910-20. PubMed ID: 15504972 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. Du X; Matsumura T; Edelstein D; Rossetti L; Zsengellér Z; Szabó C; Brownlee M J Clin Invest; 2003 Oct; 112(7):1049-57. PubMed ID: 14523042 [TBL] [Abstract][Full Text] [Related]
31. Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF. Tilton RG Microsc Res Tech; 2002 Jun; 57(5):390-407. PubMed ID: 12112445 [TBL] [Abstract][Full Text] [Related]
32. Negative consequences of glycation. Brownlee M Metabolism; 2000 Feb; 49(2 Suppl 1):9-13. PubMed ID: 10693913 [TBL] [Abstract][Full Text] [Related]
33. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions. Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409 [TBL] [Abstract][Full Text] [Related]
34. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654 [TBL] [Abstract][Full Text] [Related]
35. Effect of the postprandial state on nontraditional risk factors. Lebovitz HE Am J Cardiol; 2001 Sep; 88(6A):20H-5H. PubMed ID: 11576522 [TBL] [Abstract][Full Text] [Related]
36. Molecular targets of diabetic cardiovascular complications. Ahmad FK; He Z; King GL Curr Drug Targets; 2005 Jun; 6(4):487-94. PubMed ID: 16026267 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes. Groop PH; Forsblom C; Thomas MC Nat Clin Pract Endocrinol Metab; 2005 Dec; 1(2):100-10. PubMed ID: 16929378 [TBL] [Abstract][Full Text] [Related]
38. Biochemical and molecular mechanisms in the development of diabetic vascular complications. King GL; Kunisaki M; Nishio Y; Inoguchi T; Shiba T; Xia P Diabetes; 1996 Jul; 45 Suppl 3():S105-8. PubMed ID: 8674872 [TBL] [Abstract][Full Text] [Related]
39. [Genetic susceptibility to microangiopathy development in Type 1 diabetes mellitus]. Corrêa-Giannella ML; Vieira SM Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):375-86. PubMed ID: 18438549 [TBL] [Abstract][Full Text] [Related]